Global Famciclovir API Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Famciclovir API Market
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

Due to the COVID-19 pandemic, the global Famciclovir API market size is estimated to be worth US$ 13 million in 2022 and is forecast to a readjusted size of US$ 15 million by 2028 with a CAGR of 2.3% during the review period. Fully considering the economic change by this health crisis, Insourced accounting for % of the Famciclovir API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tablet Product segment is altered to an % CAGR throughout this forecast period.

The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.

Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.

Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.

Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Insourced

Outsourced

Others

Segment by Application

Tablet Product

Capsule Product

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Famciclovir API market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Chongqing Shenghuaxi Pharma

Aurobindo Pharma Limited

Apotex Pharmachem

Changzhou Kony Pharma Co

Teva Pharmaceutical Industries

Olon

Fuan Pharmaceutical

Zhejiang Charioteer Pharmaceutical

Jialin Pharmaceutical

Zhejiang Hisun

Hetero

TABLE OF CONTENT

1 Study Coverage
1.1 Famciclovir API Product Introduction

1.2 Market by Type

1.2.1 Global Famciclovir API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Insourced

1.2.3 Outsourced

1.2.4 Others

1.3 Market by Application

1.3.1 Global Famciclovir API Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Tablet Product

1.3.3 Capsule Product

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Famciclovir API Sales Estimates and Forecasts 2017-2028

2.2 Global Famciclovir API Revenue Estimates and Forecasts 2017-2028

2.3 Global Famciclovir API Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Famciclovir API Sales by Region

2.4.1 Global Famciclovir API Sales by Region (2017-2022)

2.4.2 Global Sales Famciclovir API by Region (2023-2028)

2.5 Global Famciclovir API Revenue by Region

2.5.1 Global Famciclovir API Revenue by Region (2017-2022)

2.5.2 Global Famciclovir API Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Famciclovir API Sales by Manufacturers

3.1.1 Global Top Famciclovir API Manufacturers by Sales (2017-2022)

3.1.2 Global Famciclovir API Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Famciclovir API in 2021

3.2 Global Famciclovir API Revenue by Manufacturers

3.2.1 Global Famciclovir API Revenue by Manufacturers (2017-2022)

3.2.2 Global Famciclovir API Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Famciclovir API Revenue in 2021

3.3 Global Famciclovir API Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Famciclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Famciclovir API Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Famciclovir API Sales by Type

4.1.1 Global Famciclovir API Historical Sales by Type (2017-2022)

4.1.2 Global Famciclovir API Forecasted Sales by Type (2023-2028)

4.1.3 Global Famciclovir API Sales Market Share by Type (2017-2028)

4.2 Global Famciclovir API Revenue by Type

4.2.1 Global Famciclovir API Historical Revenue by Type (2017-2022)

4.2.2 Global Famciclovir API Forecasted Revenue by Type (2023-2028)

4.2.3 Global Famciclovir API Revenue Market Share by Type (2017-2028)

4.3 Global Famciclovir API Price by Type

4.3.1 Global Famciclovir API Price by Type (2017-2022)

4.3.2 Global Famciclovir API Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Famciclovir API Sales by Application

5.1.1 Global Famciclovir API Historical Sales by Application (2017-2022)

5.1.2 Global Famciclovir API Forecasted Sales by Application (2023-2028)

5.1.3 Global Famciclovir API Sales Market Share by Application (2017-2028)

5.2 Global Famciclovir API Revenue by Application

5.2.1 Global Famciclovir API Historical Revenue by Application (2017-2022)

5.2.2 Global Famciclovir API Forecasted Revenue by Application (2023-2028)

5.2.3 Global Famciclovir API Revenue Market Share by Application (2017-2028)

5.3 Global Famciclovir API Price by Application

5.3.1 Global Famciclovir API Price by Application (2017-2022)

5.3.2 Global Famciclovir API Price Forecast by Application (2023-2028)

6 North America

6.1 North America Famciclovir API Market Size by Type

6.1.1 North America Famciclovir API Sales by Type (2017-2028)

6.1.2 North America Famciclovir API Revenue by Type (2017-2028)

6.2 North America Famciclovir API Market Size by Application

6.2.1 North America Famciclovir API Sales by Application (2017-2028)

6.2.2 North America Famciclovir API Revenue by Application (2017-2028)

6.3 North America Famciclovir API Market Size by Country

6.3.1 North America Famciclovir API Sales by Country (2017-2028)

6.3.2 North America Famciclovir API Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Famciclovir API Market Size by Type

7.1.1 Europe Famciclovir API Sales by Type (2017-2028)

7.1.2 Europe Famciclovir API Revenue by Type (2017-2028)

7.2 Europe Famciclovir API Market Size by Application

7.2.1 Europe Famciclovir API Sales by Application (2017-2028)

7.2.2 Europe Famciclovir API Revenue by Application (2017-2028)

7.3 Europe Famciclovir API Market Size by Country

7.3.1 Europe Famciclovir API Sales by Country (2017-2028)

7.3.2 Europe Famciclovir API Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Famciclovir API Market Size by Type

8.1.1 Asia Pacific Famciclovir API Sales by Type (2017-2028)

8.1.2 Asia Pacific Famciclovir API Revenue by Type (2017-2028)

8.2 Asia Pacific Famciclovir API Market Size by Application

8.2.1 Asia Pacific Famciclovir API Sales by Application (2017-2028)

8.2.2 Asia Pacific Famciclovir API Revenue by Application (2017-2028)

8.3 Asia Pacific Famciclovir API Market Size by Region

8.3.1 Asia Pacific Famciclovir API Sales by Region (2017-2028)

8.3.2 Asia Pacific Famciclovir API Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Famciclovir API Market Size by Type

9.1.1 Latin America Famciclovir API Sales by Type (2017-2028)

9.1.2 Latin America Famciclovir API Revenue by Type (2017-2028)

9.2 Latin America Famciclovir API Market Size by Application

9.2.1 Latin America Famciclovir API Sales by Application (2017-2028)

9.2.2 Latin America Famciclovir API Revenue by Application (2017-2028)

9.3 Latin America Famciclovir API Market Size by Country

9.3.1 Latin America Famciclovir API Sales by Country (2017-2028)

9.3.2 Latin America Famciclovir API Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Famciclovir API Market Size by Type

10.1.1 Middle East and Africa Famciclovir API Sales by Type (2017-2028)

10.1.2 Middle East and Africa Famciclovir API Revenue by Type (2017-2028)

10.2 Middle East and Africa Famciclovir API Market Size by Application

10.2.1 Middle East and Africa Famciclovir API Sales by Application (2017-2028)

10.2.2 Middle East and Africa Famciclovir API Revenue by Application (2017-2028)

10.3 Middle East and Africa Famciclovir API Market Size by Country

10.3.1 Middle East and Africa Famciclovir API Sales by Country (2017-2028)

10.3.2 Middle East and Africa Famciclovir API Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Chongqing Shenghuaxi Pharma

11.1.1 Chongqing Shenghuaxi Pharma Corporation Information

11.1.2 Chongqing Shenghuaxi Pharma Overview

11.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Chongqing Shenghuaxi Pharma Recent Developments

11.2 Aurobindo Pharma Limited

11.2.1 Aurobindo Pharma Limited Corporation Information

11.2.2 Aurobindo Pharma Limited Overview

11.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Aurobindo Pharma Limited Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Aurobindo Pharma Limited Recent Developments

11.3 Apotex Pharmachem

11.3.1 Apotex Pharmachem Corporation Information

11.3.2 Apotex Pharmachem Overview

11.3.3 Apotex Pharmachem Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Apotex Pharmachem Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Apotex Pharmachem Recent Developments

11.4 Changzhou Kony Pharma Co

11.4.1 Changzhou Kony Pharma Co Corporation Information

11.4.2 Changzhou Kony Pharma Co Overview

11.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Changzhou Kony Pharma Co Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Changzhou Kony Pharma Co Recent Developments

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Corporation Information

11.5.2 Teva Pharmaceutical Industries Overview

11.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Teva Pharmaceutical Industries Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Teva Pharmaceutical Industries Recent Developments

11.6 Olon

11.6.1 Olon Corporation Information

11.6.2 Olon Overview

11.6.3 Olon Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Olon Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Olon Recent Developments

11.7 Fuan Pharmaceutical

11.7.1 Fuan Pharmaceutical Corporation Information

11.7.2 Fuan Pharmaceutical Overview

11.7.3 Fuan Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Fuan Pharmaceutical Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Fuan Pharmaceutical Recent Developments

11.8 Zhejiang Charioteer Pharmaceutical

11.8.1 Zhejiang Charioteer Pharmaceutical Corporation Information

11.8.2 Zhejiang Charioteer Pharmaceutical Overview

11.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments

11.9 Jialin Pharmaceutical

11.9.1 Jialin Pharmaceutical Corporation Information

11.9.2 Jialin Pharmaceutical Overview

11.9.3 Jialin Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Jialin Pharmaceutical Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Jialin Pharmaceutical Recent Developments

11.10 Zhejiang Hisun

11.10.1 Zhejiang Hisun Corporation Information

11.10.2 Zhejiang Hisun Overview

11.10.3 Zhejiang Hisun Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Zhejiang Hisun Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Zhejiang Hisun Recent Developments

11.11 Hetero

11.11.1 Hetero Corporation Information

11.11.2 Hetero Overview

11.11.3 Hetero Famciclovir API Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Hetero Famciclovir API Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Hetero Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Famciclovir API Industry Chain Analysis

12.2 Famciclovir API Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Famciclovir API Production Mode & Process

12.4 Famciclovir API Sales and Marketing

12.4.1 Famciclovir API Sales Channels

12.4.2 Famciclovir API Distributors

12.5 Famciclovir API Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Famciclovir API Industry Trends

13.2 Famciclovir API Market Drivers

13.3 Famciclovir API Market Challenges

13.4 Famciclovir API Market Restraints

14 Key Findings in The Global Famciclovir API Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample